Switch to aflibercept or ranibizumab after initial treatment with bevacizumab in eyes with neovascular AMD

To evaluate changes in central macular thickness (CMT) and visual outcome in patients with neovascular age-related macular degeneration (AMD) treated initially with bevacizumab and subsequently switched to eit...

Source: BMC Ophthalmology - May 23, 2017 Category: Opthalmology Authors: Maria Waizel, Margarita G. Todorova, Michael Masyk, Katharina Wolf, Annekatrin Rickmann, Khaled Helaiwa, Bj örn R. Blanke and Peter Szurman Source Type: research